Humacyte (HUMA) Metrics: History & Chart

Humacyte, Inc.(HUMA)

Biotechnology · Durham, NC

$0.49-0.01 (-2.02%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

About Humacyte, Inc.

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These investigational HAVs are specifically crafted for universal compatibility, enabling easy implantation into any patient without inducing an immune rejection or an adverse foreign body response. Humacyte is currently building a pipeline of HAVs targeting the substantial market for vascular repair, reconstruction, and replacement. This includes applications such as treating vascular trauma, providing arteriovenous access for hemodialysis, addressing peripheral arterial disease, and facilitating coronary artery bypass grafting. Furthermore, the company is exploring the use of its HAVs for pediatric heart surgeries and for cellular therapeutic delivery, including the transplantation of pancreatic islet cells to manage Type 1 diabetes. Founded in 2004, Humacyte maintains its headquarters in Durham, North Carolina.

Durham, NC

184 employees

www.humacyte.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Laura E. Niklason

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-8.63%
30D Total Return	-17.34%
YTD Total Return	-47.94%
1Y Total Return	-76.19%
3Y Total Return	-82.33%
5Y Total Return	-95.29%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-47.94%
2025	-80.98%
2024	+77.82%
2023	+34.60%
2022	-70.90%
2021	-28.71%
2020

CAGR TTM	-76.03%
CAGR 3Y	-43.88%
CAGR 5Y	-45.73%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	8.31
PE Ratio Avg TTM	8.03
PE Ratio Avg 3Y	8.03
Current VS TTM Avg	+3.47%
Current VS 3Y Avg	+3.47%
Current VS 5Y Avg	+3.47%

All Metrics

HUMA Valuation Metrics

HUMA Stock Price Metrics

HUMA Dividend Metrics

HUMA Growth Rate Metrics

HUMA Discounted Cash Flow Metrics

HUMA Returns By Period

HUMA Yearly Returns

HUMA Average Annual Returns By Period (CAGR)

HUMA Revenue Metrics

HUMA PE Ratio Metrics

HUMA PS Ratio Metrics

HUMA PB Ratio Metrics

HUMA Price to Free Cash Flow Ratio Metrics

HUMA Debt to Equity Ratio Metrics

HUMA PEG Ratio Metrics

HUMA FCF Yield

HUMA Earnings Yield

HUMA EBITDA Yield

HUMA OCF Yield

HUMA EV/EBIT Ratio Metrics

HUMA EV/EBITDA Ratio Metrics

HUMA EV/Assets Ratio Metrics

HUMA EV/Sales Ratio Metrics

HUMA Current Ratio Metrics

HUMA Quick Ratio Metrics

HUMA ROIC Metrics

HUMA Return on Assets Metrics

HUMA Return on Equity Metrics

HUMA Net Profit Margin Metrics

HUMA Gross Profit Margin Metrics

HUMA Tax Rate Metrics

PS Ratio	55.21
PS Ratio Avg TTM	47.54
PS Ratio Avg 3Y	42.12
Current VS TTM Avg	+16.14%
Current VS 3Y Avg	+31.08%
Current VS 5Y Avg	-71.50%

PB Ratio	3.75
PB Ratio Avg TTM	25.36
PB Ratio Avg 3Y	21.85
Current VS TTM Avg	-85.21%
Current VS 3Y Avg	-82.84%
Current VS 5Y Avg	-48.81%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	2.12
Debt/Equity Ratio Avg TTM	8.62
Debt/Equity Ratio Avg 3Y	0.66
Current VS TTM Avg	-75.43%
Current VS 3Y Avg	+222.43%
Current VS 5Y Avg	+126.57%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	12.03%
Earnings Yield Avg TTM	12.62%
Earnings Yield Avg 3Y	12.62%
Current VS TTM Avg	-4.64%
Current VS 3Y Avg	-4.64%
Current VS 5Y Avg	-4.64%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.75
Ev/Assets Ratio Avg TTM	1.69
Ev/Assets Ratio Avg 3Y	2.60
Current VS TTM Avg	-55.68%
Current VS 3Y Avg	-71.19%
Current VS 5Y Avg	-54.86%

Ev/Sales Ratio	48.74
Ev/Sales Ratio Avg TTM	51.71
Ev/Sales Ratio Avg 3Y	43.32
Current VS TTM Avg	-5.74%
Current VS 3Y Avg	+12.51%
Current VS 5Y Avg	-66.06%

Current Ratio	6.21
Current Ratio Avg TTM	3.58
Current Ratio Avg 3Y	4.67
Current VS TTM Avg	+73.43%
Current VS 3Y Avg	+32.82%
Current VS 5Y Avg	+2.60%

Quick Ratio	5.74
Quick Ratio Avg TTM	2.97
Quick Ratio Avg 3Y	4.41
Current VS TTM Avg	+93.51%
Current VS 3Y Avg	+30.25%
Current VS 5Y Avg	-12.32%

ROIC	(90.27%)
ROIC Avg 3Y	(90.80%)
ROIC Avg 5Y	(75.93%)
Current VS 3Y Avg	+0.58%
Current VS 5Y Avg	-18.89%
Current VS 10Y Avg	-20.17%

ROA	(70.05%)
ROA Avg TTM	(22.03%)
ROA Avg 3Y	(22.56%)
Current VS TTM Avg	-217.92%
Current VS 3Y Avg	-210.49%
Current VS 5Y Avg	-298.46%

ROE	(309.44%)
ROE Avg TTM	(574.50%)
ROE Avg 3Y	(424.74%)
Current VS TTM Avg	+46.14%
Current VS 3Y Avg	+27.15%
Current VS 5Y Avg	-144.48%

Net Profit Margin	(4560.82%)
Net Profit Margin Avg TTM	(6554.32%)
Net Profit Margin Avg 3Y	(1148.58%)
Current VS TTM Avg	+30.42%
Current VS 3Y Avg	-297.08%
Current VS 5Y Avg	-85.33%

Gross Profit Margin	(736.46%)
Gross Pft Margin Avg TTM	(702.69%)
Gross Pft Margin Avg 3Y	(126.55%)
Current VS TTM Avg	-4.81%
Current VS 3Y Avg	-481.95%
Current VS 5Y Avg	-75.25%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A